Autoimmune Hepatitis Presenting as Acute Hepatitis
Approximately 25-40% of autoimmune hepatitis (AIH) cases present as acute hepatitis, characterized by jaundice, markedly elevated transaminases (often several thousand IU/L), and symptoms mimicking acute viral hepatitis including anorexia, nausea, and influenza-like symptoms. 1, 2
Clinical Scenarios for Acute Presentation
Two Distinct Entities
The acute presentation of AIH encompasses two different clinical situations 2, 3, 4:
1. Acute Exacerbation of Chronic AIH (Most Common)
- Represents acute flare of previously undiagnosed or misdiagnosed chronic disease
- Underlying chronic histological changes present (fibrosis, cirrhosis)
- Accounts for majority of "acute" presentations
- May occur in 14% of established AIH patients 5
2. Genuine Acute-Onset AIH (Less Common)
- True acute hepatitis without pre-existing chronic liver disease
- Histology shows acute changes without significant fibrosis
- Characterized by centrilobular necrosis and lobular hepatitis 1, 3, 6
- Younger patients more likely to have this form 6
Specific Triggering Factors
Drug-Associated AIH 1:
- Minocycline and nitrofurantoin (most common)
- Infliximab
- Ezetimibe
- Herbal medicines
- Atypically, patients often took the drug for months to years before presentation
- Represents approximately 9% of AIH cases
Post-Infectious Triggers 1:
- Hepatitis A virus
- Hepatitis E virus
- Cytomegalovirus (CMV)
- Epstein-Barr virus (EBV)
- Cases present shortly after documented infection
Diagnostic Challenges in Acute Presentation
Critical Pitfalls
Seronegative Presentation 2, 7, 8:
- ANA/SMA absent or weakly positive in 29-39% of acute severe cases
- IgG levels normal in 25-39% of acute presentations
- Autoantibodies may only become positive months later
- Do not wait for autoantibody positivity or demonstration of chronicity before treating
Atypical Histology 1:
- Lobular hepatitis and centrilobular necrosis common
- Interface hepatitis may be less prominent
- Cirrhosis less common than in chronic presentations
- Plasma cell infiltration still helpful diagnostic feature
Severity Spectrum of Acute Presentation
Acute Severe AIH (AS-AIH) 9, 10:
- Jaundice with INR ≥1.5 but without encephalopathy
- Represents intermediate severity
- 60-70% respond to corticosteroids without transplantation
- Good prognosis if treated promptly 1
AIH-Related Acute Liver Failure (AIH-ALF) 9, 8:
- Presence of hepatic encephalopathy
- Occurs in 3-6% of AIH patients at presentation
- Poor outcome: only 9-32% recover without transplantation
- Urgent liver transplant evaluation mandatory
- Heterogeneous hypoattenuated regions on non-contrast CT in 65% of cases 7
Acute-on-Chronic Liver Failure (ACLF) 7, 9:
- Acute flare in patients with unrecognized cirrhosis
- ANA-negative in up to 49% of cases
- Interface activity present in 90%, hepatic necrosis in 56%
- May benefit from corticosteroids but requires expedited transplant consideration
Age-Related Patterns
Elderly Patients 1:
- More likely to present with cirrhosis complications (ascites, variceal bleeding)
- May have decompensated cirrhosis at presentation
- 30% have cirrhosis at diagnosis across all age groups
Younger Patients 6:
- More likely to have genuine acute-onset AIH without chronic changes
- Higher frequency of histological acute hepatitis pattern
Essential Differential Diagnosis
When encountering acute hepatitis presentation, immediately exclude 9, 11:
For Acute Presentations:
- Drug-induced liver injury (most important mimic)
- Wilson's disease (mandatory in patients <40 years)
- Acute viral hepatitis (HAV, HEV, CMV, EBV)
- Ischemic hepatitis
- Acute cholangitis with bile duct stones
Key Distinguishing Features:
- Liver biopsy showing plasma cell infiltration favors AIH
- Zone 3 necrosis characteristic but not specific 6, 12
- Response to corticosteroids supports diagnosis
- Drug withdrawal without improvement suggests AIH over DILI
Management Implications
Critical Action Points:
Do not delay treatment waiting for demonstration of chronicity over weeks/months 1
Liver biopsy is mandatory before starting immunosuppression unless risks clearly outweigh benefits 9
Prompt corticosteroid therapy improves outcomes significantly in acute presentations 1
Refer to transplant center if INR ≥2.0 or any encephalopathy develops 1, 9
Comprehensive drug history essential - consider stopping any medication started within 12 months 9
The acute presentation of AIH represents a diagnostic emergency requiring high clinical suspicion, particularly when autoantibodies are absent and the clinical picture mimics viral hepatitis. Early recognition and treatment are critical to prevent progression to liver failure.